Abstract
COVID-19 disease caused by the novel SARS-CoV-2 virus represents a new challenge for healthcare systems. The molecular confirmation of infection is crucial to guide public health decision-making. This task could be made more difficult during the next influenza season. Thus, a rapid and user-friendly diagnostic test to discriminate SARS-CoV-2 from influenza viruses is urgently needed. Here, we present a multiplex quantitative polymerase chain reaction (qPCR) assay capable of distinguishing SARS-CoV-2 from influenza A and B cases. This assay benefits from the use of an inhibitor tolerant PCR mix which obviates the need for the rate-limiting extraction step, allowing for a more rapid and accurate analysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Seki M (2021) Trends in the management of infectious disease under SARS-CoV-2 era: from pathophysiological comparison of COVID-19 and influenza. World J Virol 10(2):62–68. https://doi.org/10.5501/wjv.v10.i2.62
Liu L, Zeng F, Rao J et al (2021) Comparison of clinical features and outcomes of medically attended COVID-19 and influenza patients in a defined population in the 2020 respiratory virus season. Front Public Health 9:587425. https://doi.org/10.3389/fpubh.2021.587425
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/strategies-and-plans
Ni M, Xu H, Luo J et al (2021) Simultaneous detection and differentiation of SARS-CoV-2, influenza A virus and influenza B virus by one-step quadruplex real-time RT-PCR in patients with clinical manifestations. Int J Infect Dis 103:517–524
Pabbaraju K, Wong AA, Ma R et al (2021) Development and validation of a multiplex reverse transcriptase-PCR assay for simultaneous testing of influenza A, influenza B and SARS-CoV-2. J Virol Methods 293:114151. https://doi.org/10.1016/j.jviromet.2021.114151. Online ahead of print
Nörz D, Hoffmann A, Aepfelbacher M et al (2021) Clinical evaluation of a fully automated, laboratory-developed multiplex RT-PCR assay integrating dual-target SARS-CoV-2 and influenza A/B detection on a high-throughput platform. J Med Microbiol 70(2). https://doi.org/10.1099/jmm.0.001295
Hawkins SFC, Guest PC (2017) Multiplex analyses using real-time quantitative PCR. Methods Mol Biol 1546:125–133
Calvez R, Taylor A, Calvo-Bado L et al (2020) Molecular detection of SARS-CoV-2 using a reagent-free approach. PLoS One 15(12):e0243266. https://doi.org/10.1371/journal.pone.0243266
RodrÃguez Flores SN, RodrÃguez-MartÃnez LM et al (2021) Comparison between a standard and SalivaDirect RNA extraction protocol for molecular diagnosis of SARS-CoV-2 using nasopharyngeal swab and saliva clinical samples. Front Bioeng Biotechnol 9:638902. https://doi.org/10.3389/fbioe.2021.638902
Fassy J, Lacoux C, Leroy S et al (2021) Versatile and flexible microfluidic qPCR test for high-throughput SARS-CoV-2 and cellular response detection in nasopharyngeal swab samples. PLoS One 16(4):e0243333. https://doi.org/10.1371/journal.pone.0243333
https://meridianlifescience.com/documents/Molecular/Meridian%20COVID%20flyer.pdf
https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html
Lee HK, Lee CK, Loh TP et al (2011) Missed diagnosis of influenza B virus due to nucleoprotein sequence mutations, Singapore, April 2011. Euro Surveill 16(33):19943
Conflict of Interest Statement
SFH is an employee of Meridian Bioscience.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Hawkins, S.F.C., Guest, P.C. (2022). Multiplex Quantitative Polymerase Chain Reaction Diagnostic Test for SARS-CoV-2 and Influenza A/B Viruses. In: Guest, P.C. (eds) Multiplex Biomarker Techniques. Methods in Molecular Biology, vol 2511. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2395-4_4
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2395-4_4
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2394-7
Online ISBN: 978-1-0716-2395-4
eBook Packages: Springer Protocols